-
Changes in alternative splicing and associated neo-antigens due to therapy
Study
EGAS00001004524
-
Conserved interferon-gamma signaling and decreased immune exclusion programs in responses to immune checkpoint blockade therapy
Study
EGAS00001004545
-
A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population
Study
EGAS00001006005
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM67 WES
Study
EGAS00001004555
-
Novel mutations in TOP2A in gliomas
Study
EGAS00001004556
-
Cancer and germline exomes, and cancer RNA-seq consisiting of FASTQ paired-end reads from melanoma, lung and colon cancer samples
Study
EGAS00001005513
-
Dynamic N6-methyladenosine Epitranscriptomic Landscape in Lung Adenocarcinoma
Study
EGAS00001005524
-
Microenvironment subtypes and association with tumor cell mutations and antigen expression in follicular lymphoma
Study
EGAS00001006052
-
Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocarcinogenesis
Study
EGAS00001004629
-
Mutational landscape of eccrine porocarcinoma (sweat gland tumour)
Study
EGAS00001004632